You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information

Oncology & Genetics

Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients.

Products

Xpert® BCR-ABL Ultra

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Learn More


Xpert® BCR-ABL Ultra p190 (RUO)  

Quantitative assay for the BCR-ABL minor breakpoint (p190) transcript. For Research Use Only (RUO). Not for use in diagnostic procedures.

Learn More


Xpert® FII & FV

30-Minute Test for Genetic Risk of Thrombosis

Learn More


Back to Top